Bryn Mawr Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.5M | Buy |
48,881
+1,266
| +3% | +$349K | 0.74% | 30 |
|
2025
Q1 | $12.6M | Buy |
47,615
+7,239
| +18% | +$1.92M | 0.76% | 33 |
|
2024
Q4 | $9.38M | Sell |
40,376
-1,618
| -4% | -$376K | 0.51% | 53 |
|
2024
Q3 | $9.27M | Sell |
41,994
-13,393
| -24% | -$2.96M | 0.5% | 54 |
|
2024
Q2 | $10.9M | Sell |
55,387
-28,454
| -34% | -$5.59M | 0.6% | 43 |
|
2024
Q1 | $11.5M | Buy |
83,841
+80,993
| +2,844% | +$11.1M | 0.65% | 41 |
|
2023
Q4 | $600K | Buy |
2,848
+176
| +7% | +$37.1K | 0.04% | 262 |
|
2023
Q3 | $535K | Buy |
2,672
+904
| +51% | +$181K | 0.04% | 270 |
|
2023
Q2 | $328K | Buy |
+1,768
| New | +$328K | 0.03% | 239 |
|
2022
Q3 | – | Sell |
-1,028
| Closed | -$210K | – | 144 |
|
2022
Q2 | $210K | Buy |
1,028
+1
| +0.1% | +$204 | 0.07% | 143 |
|
2022
Q1 | $244K | Buy |
+1,027
| New | +$244K | 0.07% | 142 |
|